Product Name | MF | CAS | Details |
---|
glutinone | C30H48O | 508-09-8 | Details |
H-DDQSIQK^-OH | Details |
Euphohelioscopin A | C30H42O6 | 87064-61-7 | Details |
ELA-14 negative control | C72H112N22O17S2 | 1885873-44-8 | Details |
7-Bromo-5-methyl-1,2,3,4-tetrahydroisoquinoline | C10H12BrN | 1934800-64-2 | Details |
FJX1 antibody | Details |
7-Hydroxy Methotrexate Ammonium Salt | C20H25N9O6 | Details |
Factor VII antibody (FITC) | Details |
6-(5-Methylthiophen-2-yl)-1-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | C15H15N3O2S | 924232-60-0 | Details |
TP 0586352 | C26H31N5O3 | 2427626-11-5 | Details |
4-(Hydroxymethyl)benzamidoxime | C8H10N2O2 | 635702-23-7 | Details |
Betulinaldehyde | C30H48O2 | 13159-28-9 | Details |
Thiamine galactoside | C18H27O6N4S.C2H3O2 | 260370-52-3 | Details |
7-Chloropyrazolo[1,5-a]pyrimidin-5-amine | C6H5ClN4 | 1189852-04-7 | Details |
4-[(5-Bromopyrimidin-2-yl)oxy]phenol | C10H7BrN2O2 | 69033-88-1 | Details |
2-(2-Diethylamino)ethylpyridine | C11H18N2 | 25877-30-9 | Details |
IACS-8968 (R-enantiomer) | C17H18F3N5O2 | 2239305-67-8 | Details |
Benzyl[3-(difluoromethoxy)propyl]amine | C11H15F2NO | 1593441-93-0 | Details |
1-(Bicyclo[2.2.2]oct-1-yl)methanamine hydrochloride | C9H18ClN | 5561-74-0 | Details |
4-(Phenylazo)diphenylamine | C18H15N3 | 101-75-7 | Details |
(5-Amino-1-butyl-1H-1,3-benzodiazol-2-yl)methanol | C12H17N3O | 1224322-32-0 | Details |
1-Bromo-3-(2,2,2-Trifluoroethyl)Benzene | C8H6BrF3 | 163975-05-1 | Details |
4-Amino-2-(propan-2-yloxy)benzamide | C10H14N2O2 | 1319746-16-1 | Details |
N-alpha-Tosyl-L-arginine methyl ester hydrochloride | C14H23ClN4O4S | 1784-03-8 | Details |
Amosulalol | C18H24N2O5S | 85320-68-9 | Details |
ANP (7-23) | Details |
5,7-dioxa-6-thiaspiro[2.5]octane-6,6-dione | C5H8O4S | 153493-52-8 | Details |
2-Chloro-5-(1H-pyrrol-1-yl)aniline | C10H9ClN2 | 878722-12-4 | Details |
1-Bromo-2,2-dimethylbutane | C6H13Br | 62168-42-7 | Details |
6-Bromo-2,3-difluorobenzodifluoride | C7H3BrF4 | 1804909-75-8 | Details |
2-(Benzylsulfanyl)-1,3-oxazole-4-carboxylic acid | C11H9NO3S | 1564705-28-7 | Details |
SU 11274 | C28H30ClN5O4S | 658084-23-2 | Details |
1-[(5-Ethyl-1,2,4-oxadiazol-3-yl)methyl]piperazine dihydrochloride | C9H17ClN4O | 1269151-73-6 | Details |
N-[4-(benzyloxy)phenyl]-1-phenylcyclopentane-1-carboxamide | C25H25NO2 | 339360-39-3 | Details |
Pyridoxine-5'-phosphate | C8H12NO6P | 447-05-2 | Details |
SRR protein (His tag) | Details |
Anti-IL12A antibody R1G - 0.5mg/mL | Details |
3-(4-Methylphenyl)pyrrolidine hydrochloride | C11H16ClN | 1187172-68-4 | Details |
A 66 | C17H23N5O2S2 | 1166227-08-2 | Details |
Daunorubicin-d3 | Details |
(2S)-1-(Pyrrolidin-1-yl)propan-2-ol | C7H15NO | 1187307-97-6 | Details |
1-hydroxy-6,6-dimethyl-2,5,6,7-tetrahydro-2-oxabenzimidazol-4-one | C8H10N2O3 | 40345-45-7 | Details |
Methyl 2-[(4-aminonaphthalen-1-yl)oxy]acetate | C13H13NO3 | 874133-47-8 | Details |
PIP5K3 antibody | Details |
8-Bromo-7-fluoro-3-methyl-1,2,3,4-tetrahydroisoquinoline | C10H11BrFN | 1861258-47-0 | Details |
EPHB1/2 antibody (Tyr594/604) | Details |
H-FTSDYYQLY-OH | Details |
H-GLSPTVWLSV-OH | Details |
ANA IgG Positive, EBV VCA & EBNA IgG Negative EDTA Plasma | Details |
3-Bromo-5-fluoro-2-hydroxybenzoic acid | C7H4BrFO3 | 4180-42-1 | Details |
7-Hydroxy-2-naphthalene sulfonic acid sodium | C10H9NaO4S | 135-55-7 | Details |
BAM-18P | C107H148N30O26S2 | Details |
2-[3-Methyl-4-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl]acetic acid | C13H13N5O2 | 1006444-38-7 | Details |
TRKC antibody | Details |
3,4-Diaminobenzamide | C7H9N3O | 7005-37-0 | Details |
3-Cyclopropyl-3-oxo-N-phenylpropanamide | C12H13NO2 | 693793-63-4 | Details |
2-Phenylpyrazolo[1,5-a]pyridine-3-carboxylic acid | C14H10N2O2 | 80537-07-1 | Details |
4-(Trifluoromethyl)thiophenylhydrazine hydrochloride | C7H8ClF3N2S | 162258-86-8 | Details |
GSK2798745 | C25H28N6O3 | 1419609-94-1 | Details |
5-(Furan-2-yl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid | C12H6F3N3O3 | 313968-60-4 | Details |
N-Phenyliminodiacetic acid | C10H11NO4 | 1137-73-1 | Details |
8,9-Dehydrothymol isobutyrate | C14H18O2 | 38146-79-1 | Details |
Ethyl 3-methyl-3-(methylamino)butanoate hydrochloride | C8H17NO2.HCl | 1423034-07-4 | Details |
N,N'-Dimethyl-(1S,2S)-1,2-Cyclohexanediamine | C8H18N2 | 87583-89-9 | Details |
tert-Butyl azetidine-3-carboxylate hydrochloride | C8H16ClNO2 | 53871-08-2 | Details |
Histamine H4 Receptor antibody | Details |
THAP1 antibody | Details |
EREG Human | Details |
1-Bromo-3-n-octylbenzene | C14H21Br | 663949-34-6 | Details |
N-[1-(Naphthalen-2-yl)ethyl]cyclopropanamine hydrochloride | C15H18ClN | 1197803-63-6 | Details |
Methyl 3-chloro-5H,6H,7H,8H-pyrido[4,3-c]pyridazine-6-carboxylate | C9H10ClN3O2 | 39716-01-3 | Details |
CGRP antibody (HRP) | Details |
2-Bromo-1-(4-chlorophenyl)propan-1-one | C9H8BrClO | 877-37-2 | Details |
1-(2-Chloro-2-phenylacetyl)-3-methylurea | C10H11ClN2O2 | 99070-51-6 | Details |
Bordetella Pertussis Toxin Antigen | Details |
H-LEDARRLKAIYEKKK-OH | Details |
Human BMP4 ELISA Kit | Details |
5-(3-Chlorophenyl)cyclohexane-1,3-dione | C12H11ClO2 | 55579-71-0 | Details |
Ethyl (ethoxymethylene) cyanoacetate | C8H11NO3 | 94-05-3 | Details |
4-(5-tert-Butyl-1,2,4-oxadiazol-3-yl)aniline | C12H15N3O | 498547-96-9 | Details |
2-(1-Methanesulfonylcyclopropyl)propan-2-ol | C7H14O3S | 1803598-00-6 | Details |
4-Cyclopropyl-6-methoxy-1,3,5-triazin-2-amine | C7H10N4O | 92238-49-8 | Details |
5-p-Tolylnicotinic acid | C13H11NO2 | 893737-23-0 | Details |
2-Amino-3-(2-hydroxy-3-methoxyphenyl)propanoic acid | C10H13NO4 | 98758-16-8 | Details |
4-Amino-2-(trifluoromethyl)pyridine-3-carboxylic acid | C7H5F3N2O2 | 1018678-42-6 | Details |
(1-Amino-6-methoxy-2,3-dihydro-1H-inden-1-yl)methanol | C11H15NO2 | 1521074-74-7 | Details |
2-{[(tert-Butoxy)carbonyl]amino}hex-4-ynoic acid | C11H17NO4 | 183500-60-9 | Details |
Lymphotoxin beta Receptor antibody (biotin) | Details |
2-(3,4-Dimethylphenyl)-1,3-thiazole-5-carbaldehyde | C12H11NOS | 1248157-57-4 | Details |
2-(1,3-Dihydro-2-benzofuran-5-yl)acetic acid | C10H10O3 | 152149-29-6 | Details |
SARS-CoV-2 Nucleoprotein (356-370) | Details |
4-Chloro-6-methylpyridine-3-carbaldehyde | C7H6ClNO | 1060805-86-8 | Details |
SRP54 Blocking Peptide | Details |
Polycarbosilane | (C2H6Si)n | 62306-27-8 | Details |
tert-Butyl 4-(methylamino)butanoate hydrochloride | C9H20ClNO2 | 1246527-48-9 | Details |
4-Chloro-2,5-dimethylbenzoic acid | C9H9ClO2 | 90649-77-7 | Details |
[4-Methyl-2-(pentyloxy)phenyl]methanamine | C13H21NO | 1250130-58-5 | Details |
3-amino-4-(1-aza-2-benzo[3,4-d]1,3-dioxolen-5-ylvinyl)benzoic acid | C15H12N2O4 | 914636-42-3 | Details |
SGMS1 Blocking Peptide | Details |
2-Amino-3-[(2-phenylethyl)sulfanyl]propanoic acid | C11H15NO2S | 14510-18-0 | Details |
Product Total: Product Page: | ||||
200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 |